What We're Reading: Page 85
Industry reads hand-picked by our editors
Nov 01, 2023
Oct 31, 2023
Oct 30, 2023
Oct 27, 2023
-
Reuters
AbbVie raises profit forecast after Humira, newer drugs drive results beat
-
Fierce Biotech
After massive $401M raise, ElevateBio lets 13% of staff go
-
FirstWord Pharma
US approves Santhera’s Agamree for Duchenne muscular dystrophy
-
Stat
Prime Medicine says its gene editing passes test in monkeys
Oct 26, 2023
Oct 25, 2023
-
Bloomberg
Lululemon Founder Chip Wilson Races to Find Muscular Dystrophy Cure
-
Nature
An AI revolution is brewing in medicine. What will it look like?
-
Healthcare Dive
Blue Shield of California is promising a simpler, cheaper pharmacy benefits model. Can it deliver?
-
MedTech Dive
Thermo Fisher cuts 2023 forecast, citing volatile economic conditions
Oct 24, 2023
-
FirstWord Pharma
Documents reveal Mirati rebuffed $140 per share offer from BMS
-
The Wall Street Journal
Ozempic Maker Novo Nordisk Has a Weight Problem
-
NPR
Why drug shortages continue and how one woman is fighting back
-
Gizmodo
Microsoft Fixes Excel Feature That Forced Scientists to Rename Human Genes
Previous
